Connection

Michael Hallek to Clinical Trials as Topic

Back to Details
This is a "connection" page, showing publications Michael Hallek has written about Clinical Trials as Topic.
Michael Hallek
Connection Strength
0.263
Clinical Trials as Topic
  1. [Elderly patients in clinical trials: new fitness-adapted concepts]. Internist (Berl). 2007 Nov; 48(11):1232-7.
    View in: PubMed
    Score: 0.088
  2. Long-Term Studies Assessing Outcomes of Ibrutinib Therapy in Patients With Del(11q) Chronic Lymphocytic Leukemia. Clin Lymphoma Myeloma Leuk. 2019 11; 19(11):715-722.e6.
    View in: PubMed
    Score: 0.049
  3. Small Lymphocytic Lymphoma: Analysis of Two Cohorts Including Patients in Clinical Trials of the German Chronic Lymphocytic Leukemia Study Group (GCLLSG) or in "Real-Life" Outside of Clinical Trials. Anticancer Res. 2019 May; 39(5):2591-2598.
    View in: PubMed
    Score: 0.049
  4. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. Blood. 2018 06 21; 131(25):2745-2760.
    View in: PubMed
    Score: 0.045
  5. Sequential and combination treatments with novel agents in chronic lymphocytic leukemia. Haematologica. 2019 11; 104(11):2144-2154.
    View in: PubMed
    Score: 0.013
  6. Economic burden of clinical trials in lung cancer in a German Comprehensive Cancer Center. Lung Cancer. 2017 06; 108:134-139.
    View in: PubMed
    Score: 0.011
  7. Emerging therapies for refractory chronic lymphocytic leukemia. Leuk Lymphoma. 2015 Feb; 56(2):285-92.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.